Showing 61 - 80 results of 271 for search '"mitral valve disease"', query time: 0.13s Refine Results
  1. 61

    Radiographic Left Atrial Size Measurement of Dogs in Different Mitral Valve Disease Stages with Four Different Methods by David Marbella Fernández, Jose Alberto Montoya-Alonso

    Published 2023-12-01
    “…The left atrial size increases (LAS) in patients with mitral valve disease (MVD) as the disease progresses. The vertebral left atrial size (VLAS), the modified-vertebral left atrial size (M-VLAS), and the radiographic left atrial dimension (RLAD) are methods reported to assess LAS on dogs’ radiographs. …”
    Get full text
    Article
  2. 62
  3. 63

    Differentially expressed platelet activation-related genes in dogs with stage B2 myxomatous mitral valve disease by Qingqing Zhou, Xiang Cui, Han Zhou, Shuai Guo, Zhimin Wu, Liyang Li, Jinxin Zhang, Wen Feng, Yingfang Guo, Xiaofei Ma, Yu Chen, Changwei Qiu, Ming Xu, Ganzhen Deng

    Published 2023-12-01
    “…Although it is well recognized that the typical symptoms of Myxomatous Mitral Valve Disease (MMVD) stage B2 are long-standing hemodynamic disorder and cardiac structure remodeling caused by mitral regurgitation, the transcriptomic alterations in blood from such dogs are not understood. …”
    Get full text
    Article
  4. 64
  5. 65
  6. 66

    Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration by M.J. Reimann, J. Häggström, J.E. Møller, J. Lykkesfeldt, T. Falk, L.H. Olsen

    Published 2017-03-01
    “…Little is known about the relationship between myxomatous mitral valve disease (MMVD) and oxidative stress in dogs. …”
    Get full text
    Article
  7. 67

    Severe mixed mitral valve disease due to massive mitral annular calcification — a case report and literature review by Fateh Ali Tipoo Sultan, Sheema Saadia

    Published 2022-05-01
    “…To our knowledge severe mixed mitral valve disease secondary to MAC is extremely rare. …”
    Get full text
    Article
  8. 68
  9. 69
  10. 70
  11. 71

    Efficacy of a mitral regurgitation severity index to predict long‐term outcome in dogs with myxomatous mitral valve disease by Michelle Vereb, Clarke E. Atkins, Darcy Adin, Thomas Blondel, Melissa Coffman, Seunggon Lee, Emilie Guillot, Jessica L. Ward

    Published 2024-01-01
    “…Abstract Background Predicting progression of myxomatous mitral valve disease (MMVD) in dogs can be challenging. Hypothesis/Objectives The mitral regurgitation severity index (MRSI) will predict time to congestive heart failure (CHF) and all‐cause death in dogs with MMVD. …”
    Get full text
    Article
  12. 72
  13. 73

    Real‐Time 3‐Dimensional Echocardiographic Assessment of Effective Regurgitant Orifice Area in Dogs With Myxomatous Mitral Valve Disease by A. Tidholm, A. Bodegård‐Westling, K. Höglund, J. Häggström, I. Ljungvall

    Published 2017-03-01
    “…However, this simplified assumption only holds when the EROA is circular, which might not be true in dogs with myxomatous mitral valve disease (MMVD). Hypothesis Effective regurgitant orifice area in dogs with MMVD is noncircular, and using color Doppler real‐time 3‐dimensional (RT3D) echocardiography, measured EROA in the en face view will be significantly different from calculated EROA. …”
    Get full text
    Article
  14. 74
  15. 75
  16. 76
  17. 77
  18. 78

    Machine learning-based risk prediction model for canine myxomatous mitral valve disease using electronic health record data by Yunji Kim, Jaejin Kim, Sehoon Kim, Hwayoung Youn, Jihye Choi, Kyoungwon Seo

    Published 2023-08-01
    “…IntroductionMyxomatous mitral valve disease (MMVD) is the most common cause of heart failure in dogs, and assessing the risk of heart failure in dogs with MMVD is often challenging. …”
    Get full text
    Article
  19. 79

    Proteomic analysis of pulmonary arteries and lung tissues from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease. by Siriwan Sakarin, Anudep Rungsipipat, Sittiruk Roytrakul, Janthima Jaresitthikunchai, Narumon Phaonakrop, Sawanya Charoenlappanit, Siriwan Thaisakun, Sirilak Disatian Surachetpong

    Published 2024-01-01
    “…In dogs with degenerative mitral valve disease (DMVD), pulmonary hypertension (PH) is a common complication characterized by abnormally elevated pulmonary arterial pressure (PAP). …”
    Get full text
    Article
  20. 80

    Endothelin-1 gene and endothelin receptor A gene polymorphisms in severe pulmonary hypertension associated with rheumatic mitral valve disease by Pratishtha Mehra, Vimal Mehta, Jamal Yusuf, Rishi Sukhija, Wilbert S. Aronow

    Published 2022-01-01
    “…Introduction Endothelin-1 (ET-1) gene polymorphisms are implicated in pathogenesis of idiopathic pulmonary arterial hypertension Material and methods We studied ET-1 (Lys198Asn and 3A/4A) and endothelin receptor A (ETA) gene (His323His) polymorphisms in 123 subjects with pulmonary hypertension associated with rheumatic mitral valve disease (PH-MVD) and 123 healthy controls. …”
    Get full text
    Article